ClinicalTrials.Veeva

Menu

Investigating the Role of the Polyol Pathway in the Central Nervous System

Yale University logo

Yale University

Status

Completed

Conditions

Hyperglycemia

Treatments

Other: Brain MRS during hyperglycemic clamp
Other: Analysis of Metabolites in cerebrospinal fluid

Study type

Interventional

Funder types

Other

Identifiers

NCT02272556
1408014461

Details and patient eligibility

About

Patients will undergo magnetic resonance spectroscopy (MRS) scanning to noninvasively measure intracerebral and plasma metabolite levels at baseline and following 2 and 4 hours of hyperglycemia. Subjects will also undergo a lumbar puncture at a separate occasion to assess cerebrospinal fluid levels of metabolites.

Enrollment

138 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Type 2 DM with HbA1C treated with metformin, sulfonylurea, insulin, or combination OR age-matched, non-diabetic obese (BMI > 30 kg/m^2) OR age-matched lean, healthy control subjects (BMI < 25 kg/m^2)
  • Age 18-55
  • BMI 18-45 kg/m^2

Exclusion criteria

  • Creatinine > 1.5 mg/dL
  • Hgb < 10 mg/dL
  • ALT > 2.5 x ULN
  • Untreated thyroid disease
  • Uncontrolled Hypertension
  • Known Neurological Disorders
  • Untreated Psychiatric Disorders
  • Malignancy
  • Bleeding Disorders
  • Smoking
  • Current or recent steroid use in last 3 months
  • Illicit drug use
  • Pregnancy, actively seeking pregnancy, or breastfeeding
  • Inability to enter MRI/MRS

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

138 participants in 3 patient groups

Subjects with Type 2 Diabetes
Active Comparator group
Description:
Type 2 DM subjects with HbA1C \> 7.5% treated with metformin, sulfonylurea, insulin or combination
Treatment:
Other: Brain MRS during hyperglycemic clamp
Other: Analysis of Metabolites in cerebrospinal fluid
Non-Diabetic Obese
Active Comparator group
Description:
Age-matched, non-diabetic obese (BMI \> 30 kg/m\^3) individuals
Treatment:
Other: Brain MRS during hyperglycemic clamp
Other: Analysis of Metabolites in cerebrospinal fluid
Lean, healthy control subjects
Active Comparator group
Description:
Age-matched, lean, healthy control subjects (BMI \< 25 kkg/m\^3)
Treatment:
Other: Brain MRS during hyperglycemic clamp
Other: Analysis of Metabolites in cerebrospinal fluid

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems